FDA Clearance Tracker · K220641
Barrigel Injectable Gel
Last checked: Nov 19, 2026Latest source record: May 26, 2022 (this decision)Source: openFDAMethods & limitations
Decided
May 26, 2022
Substantially Equivalent
Time to decision
83 days
Received Mar 4, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K220641
- Device name
- Barrigel Injectable Gel
- Applicant
- Palette Life Sciences
- Applicant location
- Santa Barbara, CA
- Received
- Mar 4, 2022
- Decided
- May 26, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Hydrogel Spacer (OVB)
- Device class
- Class II
- Regulation
- 21 CFR 892.5725
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OVB. The earliest in FDA's data is DEN140030, decided Apr 1, 2015.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K220641
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Palette Life Sciences
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.